CPHI & PMEC China 2024 Sets New Attendance Record, Eyes South China Expansion

[cs_content _p=’4117′][cs_element_section _id=”1″ ][cs_element_layout_row _id=”2″ ][cs_element_layout_column _id=”3″ ][cs_element_text _id=”4″ ][cs_content_seo]CPHI & PMEC China 2024 concluded in June with a record-breaking turnout, highlighting the strong demand in China’s thriving pharmaceutical industry. The event saw over 11,563 international visitors and brought together professionals from across the pharmaceutical supply chain, facilitating meaningful connections, discussions, and showcasing groundbreaking innovations.
To cater to the growing demand for access to key pharmaceutical regions, CPHI & PMEC Shenzhen is set to take place from September 9-11, 2024, at the Shenzhen Convention & Exhibition Center. Shenzhen, located in Guangdong Province, is recognized as one of China’s most competitive and innovative cities. The region is home to a significant number of Specialized, Differential, Refined, and Innovational pharmaceutical companies, with Guangdong Province ranking second in the country for such enterprises.
The Greater Bay Area, encompassing Guangdong, Hong Kong, and Macau, is one of China’s most economically vibrant regions. With robust national and local policy support, it has developed into a major hub for the biopharmaceutical industry. CPHI & PMEC Shenzhen aims to leverage this dynamic environment to connect industries through new technologies, highlighting advancements in new drug research and development, and fostering collaboration across Pan Asia.
The Shenzhen event will feature over 350 exhibitors from various sectors, including pharma ingredients, finished dosages, biopharmaceuticals, contract services, machinery, laboratory instruments, and packaging solutions. This diverse representation will provide attendees with insights into the latest advancements and trends shaping the pharmaceutical industry’s future.
To enhance strategic partnerships, the event will offer exclusive Hosted Buyer Matchmaking and Plant Visit opportunities. These initiatives aim to facilitate meaningful interactions between local suppliers and international buyers with specific purchasing demands, driving business growth and success.
Attendees can expect valuable insights from thought leaders and industry pioneers during conference sessions. Topics will cover pharma manufacturing 4.0, global API trading trends, biopharmaceutical R&D, synthetic biology innovation, and regulatory updates. These sessions will offer unparalleled insights into the market trends shaping the pharmaceutical landscape.
CPHI & PMEC Shenzhen promises to be a catalyst for innovation, a dynamic platform for networking, and an opportunity for knowledge exchange and business development. With its robust lineup of exhibitors, insightful conferences, and matchmaking opportunities, the event aims to further solidify its position as a premier event in the pharmaceutical industry.
Registration for CPHI & PMEC Shenzhen 2024 is now open. Secure your place today to be part of this exciting pharmaceutical event.\n\n[/cs_content_seo][/cs_element_layout_column][/cs_element_layout_row][/cs_element_section][/cs_content]